tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
BUX
BioMark Diagnostics
RESEARCH TOOLSreports

BioMark Diagnostics (BUX) Income Statement

3 Followers

BioMark Diagnostics Income Statement

Last quarter (Q3 2026), BioMark Diagnostics's total revenue was C$6.92K, a decrease of -82.26% from the same quarter last year. In Q3, BioMark Diagnostics's net income was C$-380.32K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 22Jun 21Mar 21Mar 20
Total Revenue
C$ 154.22KC$ 153.49KC$ 43.93KC$ 0.00C$ 263.28K
Gross Profit
C$ 154.22KC$ -232.70KC$ 43.93KC$ -13.69KC$ 263.28K
Operating Expenses
C$ 2.06MC$ 1.89MC$ 1.45MC$ 1.08MC$ 1.47M
Depreciation and Amortization
C$ 401.27KC$ 386.20KC$ 179.62KC$ 13.69KC$ 11.91K
EBITDA
C$ -1.46MC$ -1.35MC$ -1.22MC$ -1.08MC$ -1.20M
Operating Income
C$ -1.91MC$ -1.84MC$ -1.28MC$ -1.09MC$ -1.18M
Other Income/Expenses
C$ -19.14KC$ -110.15KC$ -50.80KC$ -596.00C$ -8.63K
Pretax Income
C$ -1.93MC$ -1.84MC$ -1.45MC$ -1.09MC$ -1.22M
Net Income
C$ -1.93MC$ -1.84MC$ -1.45MC$ -1.09MC$ -1.22M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.02
Diluted EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.02
Weighted Average Shares Outstanding
 85.24M 82.78M 72.31M 73.30M 71.30M
Weighted Average Shares Outstanding (Diluted)
 85.24M 82.78M 72.31M 73.30M 71.30M
Currency in CAD

BioMark Diagnostics Earnings and Revenue History